These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 1827161

  • 1. Immunologic effects of plasmapheresis synchronized with pulse cyclophosphamide in systemic lupus erythematosus.
    Dau PC, Callahan J, Parker R, Golbus J.
    J Rheumatol; 1991 Feb; 18(2):270-6. PubMed ID: 1827161
    [Abstract] [Full Text] [Related]

  • 2. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus.
    Huang YP, Perrin LH, Miescher PA, Zubler RH.
    J Immunol; 1988 Aug 01; 141(3):827-33. PubMed ID: 3135313
    [Abstract] [Full Text] [Related]

  • 3. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
    Baráth S, Soltész P, Kiss E, Aleksza M, Zeher M, Szegedi G, Sipka S.
    Autoimmunity; 2007 Nov 01; 40(7):521-8. PubMed ID: 17966042
    [Abstract] [Full Text] [Related]

  • 4. Regulation of immune function by calorie restriction and cyclophosphamide treatment in lupus-prone NZB/NZW F1 mice.
    Sun D, Krishnan A, Su J, Lawrence R, Zaman K, Fernandes G.
    Cell Immunol; 2004 Mar 01; 228(1):54-65. PubMed ID: 15203320
    [Abstract] [Full Text] [Related]

  • 5. [Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus].
    Stanislav ML, Balabanova RM, Nikonova MF, Litvina MM, Iarilin AA.
    Ter Arkh; 2000 Mar 01; 72(5):44-9. PubMed ID: 11109620
    [Abstract] [Full Text] [Related]

  • 6. Anti-lymphocyte antibodies in systemic lupus erythematosus.
    Winfield JB.
    Clin Rheum Dis; 1985 Dec 01; 11(3):523-49. PubMed ID: 3907954
    [Abstract] [Full Text] [Related]

  • 7. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M, Harigai M, Hara M, Kawaguchi Y, Tezuka K, Tanaka M, Sugiura T, Katsumata Y, Fukasawa C, Ichida H, Higami S, Kamatani N.
    Arthritis Res Ther; 2006 Dec 01; 8(3):R62. PubMed ID: 16563187
    [Abstract] [Full Text] [Related]

  • 8. Plasmapheresis and subsequent pulse cyclophosphamide in severe systemic lupus erythematosus. An interim report of the Lupus Plasmapheresis Study Group.
    Euler HH, Guillevin L.
    Ann Med Interne (Paris); 1994 Dec 01; 145(5):296-302. PubMed ID: 7985935
    [Abstract] [Full Text] [Related]

  • 9. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
    Kammer GM, Birch RE, Polmar SH.
    J Immunol; 1983 Apr 01; 130(4):1706-12. PubMed ID: 6220065
    [Abstract] [Full Text] [Related]

  • 10. IgG anti-lymphocyte antibodies in systemic lupus erythematosus react with surface molecules shared by peripheral T cells and a primitive T cell line.
    Minota S, Winfield JB.
    J Immunol; 1987 Mar 15; 138(6):1750-6. PubMed ID: 3102598
    [Abstract] [Full Text] [Related]

  • 11. T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis.
    Shivakumar S, Tsokos GC, Datta SK.
    J Immunol; 1989 Jul 01; 143(1):103-12. PubMed ID: 2525144
    [Abstract] [Full Text] [Related]

  • 12. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF.
    Arthritis Rheum; 2005 Jan 01; 52(1):201-11. PubMed ID: 15641052
    [Abstract] [Full Text] [Related]

  • 13. IL-2 normalizes defective suppressor T cell function of patients with systemic lupus erythematosus in vitro.
    Volk HD, Diamantstein T.
    Clin Exp Immunol; 1986 Dec 01; 66(3):525-31. PubMed ID: 2952381
    [Abstract] [Full Text] [Related]

  • 14. Functional properties of CD8 positive lymphocyte subsets in systemic lupus erythematosus.
    Horwitz DA, Linker-Israeli M, Gray JD, Lemoine C.
    J Rheumatol Suppl; 1987 Jun 01; 14 Suppl 13():49-52. PubMed ID: 2956420
    [Abstract] [Full Text] [Related]

  • 15. The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells.
    Huang YP, Miescher PA, Zubler RH.
    J Immunol; 1986 Dec 01; 137(11):3515-20. PubMed ID: 2946762
    [Abstract] [Full Text] [Related]

  • 16. Immunoregulatory T lymphocytes in man. Soluble antigen-specific suppressor-inducer T lymphocytes are derived from the CD4+CD45R-p80+ subpopulation.
    Damle NK, Childs AL, Doyle LV.
    J Immunol; 1987 Sep 01; 139(5):1501-8. PubMed ID: 2887618
    [Abstract] [Full Text] [Related]

  • 17. Systemic lupus erythematosus with deficiency of the T4 epitope on T helper/inducer cells.
    Stohl W, Crow MK, Kunkel HG.
    N Engl J Med; 1985 Jun 27; 312(26):1671-8. PubMed ID: 2582253
    [Abstract] [Full Text] [Related]

  • 18. Effect of plasmapheresis on T anc B lymphocyte functions in patients with systemic lupus erythematosus: a double blind study.
    Tsokos GC, Balow JE, Huston DP, Wei N, Decker JL.
    Clin Exp Immunol; 1982 May 27; 48(2):449-57. PubMed ID: 6213330
    [Abstract] [Full Text] [Related]

  • 19. [Role of T lymphocytes in systemic lupus erythematosus].
    Zubler RH, Miescher PA.
    Ann Med Interne (Paris); 1990 May 27; 141(3):208-12. PubMed ID: 2195945
    [Abstract] [Full Text] [Related]

  • 20. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
    Devi BS, Van Noordin S, Krausz T, Davies KA.
    J Autoimmun; 1998 Oct 27; 11(5):471-5. PubMed ID: 9802931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.